Works matching IS 00070920 AND DT 2002 AND VI 87 AND IP 8

Results: 21

Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells.

Published in:

2002

By:

Mooney, L.M.;
Al-Sakkaf, K.A.;
Brown, B.L.;
Dobson, P.R.M.

Publication type:

journal article

Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells.

Published in:

2002

By:

Thomas, G J;
Hart, I R;
Speight, P M;
Marshall, J F

Publication type:

journal article

BAG-1 expression and function in human cancer.

Published in:

2002

By:

Cutress, R I;
Townsend, P A;
Brimmell, M;
Bateman, A C;
Hague, A;
Packham, G

Publication type:

journal article

A novel form of constitutively active farnesylated Akt i prevents mammary epithelial cells from anoikis and suppresses chemotherapy-induced apoptosis.

Published in:

British Journal of Cancer, 2002, v. 87, n. 8, p. 924, doi. 10.1038/sj.bjc.6600566

By:

Schmidt, M.;
Hovelmann, S.;
Beckers, T.L.

Publication type:

Article

Inhibition of proliferation and induction of differentiation of glioma cells with Datura stramonium agglutinin.

Published in:

British Journal of Cancer, 2002, v. 87, n. 8, p. 918, doi. 10.1038/sj.bjc.6600550

By:

Sasaki, T.;
Yamazaki, K.;
Yamori, T.;
Endo, T.

Publication type:

Article

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.

Published in:

2002

By:

Meitz, J.C.;
Edwards, S.M.;
Easton, D F;
Murkin, A;
Ardern-Jones, A;
Jackson, R A;
Williams, S;
Dearnaley, D P;
Stratton, M R;
Houlston, R S;
Eeles, R A;
Cancer Research UK/BPG UK Familial Prostate Cancer Study Collaborators

Publication type:

journal article

Hyperstable UIsnRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells.

Published in:

British Journal of Cancer, 2002, v. 87, n. 8, p. 898, doi. 10.1038/sj.bjc.6600563

By:

Kato, K.;
Hitomi, Y.;
Imamura, K.;
Esumi, H.

Publication type:

Article

Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach.

Published in:

2002

By:

Gille, J.J.P.;
Hogervorst, F.B.L.;
Pals, G;
Wijnen, J Th;
van Schooten, R J;
Dommering, C J;
Meijer, G A;
Craanen, M E;
Nederlof, P M;
de Jong, D;
McElgunn, C J;
Schouten, J P;
Menko, F H

Publication type:

journal article

BRCA2 gene mutations in families with aggregations of breast and stomach cancers.

Published in:

2002

By:

Jakubowska, A.;
Nej, K.;
Huzarski, T.;
Scott, R.J.;
Lubinski, J.;
Lubiński, J

Publication type:

journal article

Survivn messenger RNA expression is a good prognostic biomarker for eosophageal carcinoma.

Published in:

British Journal of Cancer, 2002, v. 87, n. 8, p. 883, doi. 10.1038/sj.bjc.6600546

By:

Ikeguchi, M.;
Kaibara, N.

Publication type:

Article

The association of breast mitogens with mammographic densities.

Published in:

2002

By:

Boyd, N.F.;
Stone, J.;
Martin, L.J.;
Jong, R.;
Fishell, E.;
Yaffe, M.;
Hammond, G.;
Minkin, S.

Publication type:

journal article

Role of biological markers in the clinical outcome of colon cancer.

Published in:

2002

By:

Nanni, O.;
Volpi, A.;
Frassineti, G L;
De Paola, F;
Granato, A M;
Dubini, A;
Zoli, W;
Scarpi, E;
Turci, D;
Oliverio, G;
Gambi, A;
Amadori, D

Publication type:

journal article

Binding of TGF-βI latency-associated peptide (LAP) to &alphavβ6 integrin modulates behavior of squamous carcinoma cells.

Published in:

British Journal of Cancer, 2002, v. 87, n. 8, p. 859, doi. 10.1038/sj.bjc.6600545

By:

Thomas, G.J.;
Hart, I.R.;
Speight, P.M.;
Marshall, J.F.

Publication type:

Article

Describing randomisation: patients' and the public's preferences compared with clinicians' practice.

Published in:

2002

By:

Jenkins, V.;
Leach, L.;
Fallowfield, L.;
Nicholls, K.;
Newsham, A.

Publication type:

journal article

Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen.

Published in:

2002

By:

Slater, S.;
Shamash, J.;
Wilson, P.;
Gallagher, C.J.;
Slevin, M.L.

Publication type:

journal article

Phase I study of docetaxel plus ifosfamide in patients with advanced cancer.

Published in:

2002

By:

Marx, G.;
Lewis, C.;
Ha, K.;
Levi, J.;
Ackland, S.;
Hall, K

Publication type:

journal article

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2.

Published in:

British Journal of Cancer, 2002, v. 87, n. 8, p. 840, doi. 10.1038/sj.bjc.6600521

By:

Becker, J.C.;
Terheyden, P.

Publication type:

Article

BAG-I expression and function in human cancer.

Published in:

British Journal of Cancer, 2002, v. 87, n. 8, p. 834, doi. 10.1038/sj.bjc.6600538

By:

Cutress, R.I.;
Townsend, P.A.;
Brimmell, M.;
Bateman, A.C.;
Hague, A.;
Packham, G.

Publication type:

Article

Platinum drugs in the treatment of non-small-cell lung cancer.

Published in:

2002

By:

Cosaert, J.;
Quoix, E.

Publication type:

journal article

First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence.

Published in:

2002

By:

Sandercock, J.;
Parmar, M.K.B.;
Torri, V.;
Qian, W.

Publication type:

journal article

First-line chemotherapy for ovarian cancer -- the controversy continues.

Published in:

2002

By:

Kaye, S.B.

Publication type:

Editorial